Understanding how the environment around pancreatic cancer cells affects their response to treatment
Targeting nutrient microenvironment imprinted therapy resistance in pancreatic cancer
This study is looking into why pancreatic cancer cells often don't respond well to chemotherapy by recreating the environment around the tumors, so we can find ways to make treatments work better for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11056178 on NIH RePORTER |
What this research studies
This research investigates the reasons behind the resistance of pancreatic cancer cells to chemotherapy by examining the tumor microenvironment (TME). Researchers will recreate the conditions found in pancreatic tumors to study how these factors influence the effectiveness of cancer treatments. By isolating and analyzing the nutrients available in the TME, the team aims to identify specific elements that may help improve treatment responses. This approach could lead to more effective therapies tailored to the unique conditions of pancreatic cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with pancreatic adenocarcinoma who are undergoing or considering chemotherapy.
Not a fit: Patients with non-pancreatic cancers or those who are not receiving chemotherapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for pancreatic cancer patients, enhancing their response to chemotherapy.
How similar studies have performed: Previous research has shown that understanding the tumor microenvironment can significantly impact treatment outcomes in various cancers, suggesting this approach may yield valuable insights.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Muir, Alexander — University of Chicago
- Study coordinator: Muir, Alexander
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.